Business
News
Trending
Articles
Latest
Fashion
Recent
Posts
AbbVie to create 300 new jobs with $380m Illinois manufacturing investment
AbbVie has announced a $380m investment to build two new active pharmaceutical ingredient (API) manufacturing facilities at its North Chicago campus, expanding U.S. production capacity for next-generation medicines and creating around 300 new jobs.
The new facilities will support production of AbbVie’s future neuroscience and obesity treatments, integrating advanced manufacturing technologies and artificial intelligence into API production processes. Construction is scheduled to begin in spring 2026, with both plants expected to be operational by 2029.
AbbVie CEO Robert A. Michael said the project reflects the company’s long-term commitment to U.S. manufacturing.
“This milestone demonstrates further progress against our $100bn commitment to U.S. R&D and capital investments over the next decade,” he said. “By strengthening our U.S. manufacturing capabilities, we are well-positioned to support our investment in innovation and enhance our ability to deliver next-generation medicines to patients.”
API manufacturing involves producing the active components responsible for a drug’s therapeutic effects, a complex multi-step process often outsourced globally. AbbVie has spent the past six months outlining plans to expand API capacity in the United States.
In September 2025, the company broke ground on a chemical synthesis facility intended to bring production of selected neuroscience, immunology and oncology APIs back from Europe and Asia to the U.S.
The latest investment is expected to support approximately 300 new roles in North Chicago, including engineers, scientists, manufacturing operators and laboratory technicians.
AbbVie employs around 29,000 people across the United States, including more than 6,000 at its domestic manufacturing sites and over 11,500 in Illinois. The North Chicago expansion reinforces the company’s long-standing presence in the state, where it is headquartered.
The investment also forms part of a wider U.S. manufacturing push. AbbVie recently announced plans to acquire a device manufacturing facility in Arizona and expand operations in Massachusetts, and said it is in talks with several states about additional projects expected to be announced in 2026.
AbbVie’s move reflects a wider trend across North American pharmaceutical manufacturing, where companies are investing in domestic API production to improve supply-chain resilience, meet regulatory expectations, and take advantage of government incentives.
As demand rises for obesity and neuroscience treatments, increased U.S. API capacity could play a key role in ensuring reliable supply while accelerating the adoption of advanced manufacturing technologies.
Apple to begin Mac mini production in Houston, expanding US manufacturing footprint
Stockbrokers.com director of investor research Jessica Inskip discusses investor overthinking, Apple’s ChatGPT moment and CME’s prediction market play on ‘Making Money.’
Apple will begin producing Mac minis in Houston later this year for the first time, expanding its U.S. manufacturing footprint and creating what the company said will be “thousands of jobs.”
The expansion will effectively double the size of Apple’s Houston campus and increase production of advanced artificial intelligence servers used in the company’s U.S. data centers.
Apple said Tuesday it will also open a 20,000-square-foot Advanced Manufacturing Center in Houston focused on hands-on workforce training. CEO Tim Cook said the expansion reflects the company’s previously announced commitment to increase U.S. manufacturing, adding that AI server shipments from Houston are ahead of schedule.
The Mac mini will be assembled at a new factory on the Houston campus. The company said servers built there – including logic boards manufactured onsite – are being deployed across its U.S. data center network.
ALTMAN CALLS MUSK’S SPACE DATA CENTER PLANS ‘RIDICULOUS’ FOR CURRENT AI COMPUTING NEEDS
Apple’s new manufacturing facility in Houston, Texas. (Apple)
The expansion comes as technology companies increase domestic AI infrastructure capacity and reassess overseas supply chain exposure. Apple did not disclose financial details specific to the Houston project, but it previously pledged to invest $600 billion in the U.S. and says it has surpassed some related targets.
Apple will begin producing Mac minis in Houston later this year for the first time. (Jakub Porzycki/NurPhoto via Getty Images)
As part of that broader effort, Apple said it has sourced more than 20 billion U.S.-made chips from 24 factories across 12 states, working with suppliers including TSMC, Broadcom and Texas Instruments. The company expects to purchase well over 100 million advanced chips from TSMC’s Arizona facility in 2026. It is also supporting semiconductor and materials investments in Texas, Arizona and Kentucky through partners such as Amkor, GlobalWafers and Corning.
Ticker Security Last Change Change % AAPL APPLE INC. 274.24 +2.10
+0.77%
Beyond Houston, Apple has expanded its Apple Manufacturing Academy in Detroit, which provides training in artificial intelligence, automation and smart manufacturing to small- and medium-sized U.S. businesses.
Customers line up outside of Apple’s Grove store in Los Angeles. (Eric Thayer/Bloomberg via Getty Images)
The Houston expansion is expected to generate new high-tech manufacturing roles and create additional opportunities for suppliers in the region.
CLICK HERE TO GET FOX BUSINESS ON THE GO
While Apple did not detail potential pricing implications, the increased U.S.-based production of advanced chips and AI servers reflects the company’s growing reliance on domestic facilities to support its artificial intelligence and data center operations.
Accelerating US Manufacturing and AI Ambitions
Apple deepens US manufacturing with Texas expansion & AI server production. Shareholders approve dividend increase to $0.26 per share while rejecting a China audit proposal.
In a significant strategic shift, Apple is deepening its commitment to American manufacturing, moving beyond symbolic gestures to concrete investments. The tech giant’s multi-faceted plan involves expanding production capacity in Texas, launching new training initiatives, and cultivating a domestic supplier network to regionalize its supply chains. A key question for observers is how tangible this transformation will become by the 2026 target date.
Shareholder Meeting Endorses Dividend Hike, Rejects China Audit
During its virtual annual meeting held on Tuesday, February 24, 2026, Apple’s shareholders approved several key measures. They voted in favor of increasing the quarterly cash dividend to $0.26 per share, up from the previous $0.25. This marks the fourteenth consecutive annual raise, setting the projected annual dividend at $1.04 per share. The company’s recent financial performance, including a quarterly revenue of $143.8 billion and a net profit of $42.1 billion, provides context for this shareholder return.
The meeting also saw the re-election of the entire board of directors, including Tim Cook and Art Levinson. Ernst & Young was confirmed as the independent auditor for 2026, and an updated equity plan for directors received approval. However, a shareholder proposal requesting an independent “China Entanglement Audit” was voted down.
Texas Expansion: From Macs to AI Servers
Central to Apple’s US offensive is a substantial expansion in Texas. The company plans to relocate a portion of its Mac Mini manufacturing to the United States, with production slated to begin in late 2026 at an existing facility in Houston. This move is part of a broader, four-year, $600 billion investment program designed to strengthen domestic supply chains and scale regional production.
In Houston, Apple is doubling its operational space to approximately 500,000 square feet. This will be complemented by a new 20,000-square-foot Advanced Manufacturing Training Center, scheduled to open in 2026, aimed at workforce development. Concurrently, the company is accelerating the local assembly of AI servers at the Texas site, reportedly ahead of the initial schedule.
Should investors sell immediately? Or is it worth buying Apple?
The localization efforts extend beyond Texas. Apple has already sourced billions of dollars worth of components from US-based semiconductor plants across several states. Furthermore, all new smartphones and smartwatches launching in late 2026 are expected to feature cover glass from a partner manufacturing facility in Kentucky.
Strategic Acquisition Bolsters Photonics Expertise
Nearly simultaneously, EU disclosure documents dated February 24, 2026, confirmed Apple’s acquisition of the startup invrs.io LLC. The acquired firm specializes in developing AI-powered, open-source frameworks for photonics design—a technology critical for advanced optical hardware and sensor systems.
On the trading floor, Apple’s shares showed minimal movement following these announcements, recently quoted at 230.95 Euros, reflecting a slight decline of 0.06%. Market attention is now firmly fixed on Apple’s execution, specifically its ability to successfully broaden the announced production shifts and the accelerated rollout of AI server capacity in Texas throughout 2026.
Ad
Apple Stock: New Analysis – 25 February
Fresh Apple information released. What’s the impact for investors? Our latest independent report examines recent figures and market trends.
Read our updated Apple analysis…
Hol dir den Wissensvorsprung der Aktien-Profis.
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Trading-Empfehlungen – dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt kostenlos anmelden
Jetzt abonnieren.